Osteoporosis drug Prolia faces intense competition as patents expire and generics launch Intense rivalry emerges in the ...

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

Basically, a brand-name drug company settles a patent infringement lawsuit by paying cash or transferring something else of ...

An analysis by Pharmarack, a market research firm, showed that 226 vildagliptin (anti-diabetic) brands are now available in ...

Generic versions of diabetes drug Empagliflozin launched in India, crashing prices by 80-90% on day one post-patent expiry.

The Federal Circuit’s refusal to reconsider its ruling forcing Teva to delist asthma-inhaler patents from the FDA’s Orange ...

Detailed price information for Amneal Pharmaceuticals Inc (AMRX-Q) from The Globe and Mail including charting and trades.

On March 13, 2025, the Federal Circuit decided in Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc. (No. 2023-2254) how ...

Between 2005 and 2015, nearly three-fourths of issued drug patents were for already existing drugs. A common argument in ...

A generic product cannot enter the market until the originator product’s IP has expired, but the development process can take ...